Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

被引：0
|
作者：
Zachary D Horne
David A Clump
John A Vargo
Samir Shah
Sushil Beriwal
Steven A Burton
Annette E Quinn
Matthew J Schuchert
Rodney J Landreneau
Neil A Christie
James D Luketich
Dwight E Heron
机构：
[1] University of Pittsburgh Cancer Institute,Department of Radiation Oncology
[2] University of Pittsburgh Medical Center,Division of Thorcic and Foregut Surgery, Department of Cardiothoracic Surgery
来源：
Radiation Oncology | / 9卷
关键词：
Overall Survival; Planning Target Volume; Stereotactic Body Radiation Therapy; Gross Tumor Volume; SUVmax Cutoff;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
    Pierson, Cory
    Grinchak, Taras
    Sokolovic, Casey
    Holland, Brandi
    Parent, Teresa
    Bowling, Mark
    Arastu, Hyder
    Walker, Paul
    Ju, Andrew
    RADIATION ONCOLOGY, 2018, 13
  • [42] Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: better, equivalent or worse?
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4230 - 4232
  • [43] Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs.
    Syed, Yusef
    Stokes, William A.
    Khullar, Onkar
    Sebastian, Nikhil
    Rupji, Manali
    Yuan, Liu
    Bradley, Jeffrey D.
    Higgins, Kristin Ann
    Curran, Walter J.
    Ramalingam, Suresh S.
    Sancheti, Manu
    Fernandez, Felix
    Moghanaki, Drew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] A Comparison of Stereotactic Body Radiation Therapy vs. No Treatment for Patients with Early-Stage Non-Small Cell Lung Cancer
    Jeppesen, Stefan S.
    Schytte, Tine
    Brink, Carsten
    Hansen, Niels Christian G.
    Hansen, Olfred
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S442 - S442
  • [45] SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
    Kwak, Yoo-Kang
    Park, Hee Hyun
    Choi, Kyu Hye
    Park, Eun Young
    Sung, Soo Yoon
    Lee, Sea-Won
    Hong, Ji Hyun
    Lee, Hyo Chun
    Yoo, Ie Ryung
    Kim, Yeon Sil
    CANCER RESEARCH AND TREATMENT, 2020, 52 (01): : 85 - 97
  • [46] Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
    Aridgides, Paul
    Bogart, Jeffrey
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 261 - +
  • [47] A PI3K gene expression signature predicts for recurrence in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy (SBRT)
    Sebastian, Nikhil T.
    Webb, Amy
    Shilo, Konstantin
    Robb, Ryan
    Xu-Welliver, Meng
    Haglund, Karl
    Brownstein, Jeremy
    DeNicola, Gina M.
    Shen, Changxian
    Williams, Terence M.
    CANCER, 2023, 129 (24) : 3971 - 3977
  • [48] Comorbidity is a Prognostic Factor in Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
    Chipidza, F. E.
    Franco, I.
    Chen, Y. H.
    Baldini, E. H.
    Chen, A. B.
    Kozono, D. E.
    Mak, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E677 - E677
  • [49] Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
    Huang, Karen
    Prasad, Sharan
    Ma, Sung Jun
    Yu, Han
    Iovoli, Austin J. J.
    Farrugia, Mark K. K.
    Dexter, Elizabeth U. U.
    Demmy, Todd L. L.
    Malik, Nadia K. K.
    Singh, Anurag K. K.
    BMC CANCER, 2023, 23 (01)
  • [50] Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience
    Masahiro Hiraoka
    Yasushi Nagata
    International Journal of Clinical Oncology, 2004, 9 (5) : 352 - 355
12345